Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 5/20 | 0.68 |
| ▸ | EGFR | P00533 | 2/20 | 0.50 |
| ▸ | CDK4 | P11802 | 2/20 | 0.50 |
| ▸ | CCND1 | P24385 | 2/20 | 0.50 |
| ▸ | PIM1 | P11309 | 1/20 | 0.50 |
| ▸ | BCL2 | P10415 | 1/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.45 |
| ▸ | ACLY | P53396 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 2/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.45 |
| ▸ | LIMK2 | P53671 | 1/20 | 0.45 |
| ▸ | ELANE | P08246 | 4/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16226540 | 0.91 | EPHX2 (0.65) | EPHX2EGFRCDK4CCND1PIM1 | |
| SCHEMBL16226848 | 0.89 | EPHX2 (0.65) | EPHX2EGFRCDK4CCND1PIM1 | |
| Aurantioobtusin SCHEMBL3189231 | 0.88 | EPHX2 (0.76) | EPHX2EGFRCDK4CCND1PIM1 | |
| Aurantioobtusin SCHEMBL30643536 | 0.88 | EPHX2 (0.76) | EPHX2EGFRCDK4CCND1PIM1 | |
| SCHEMBL16226235 | 0.86 | EPHX2 (0.76) | EPHX2EGFRCDK4CCND1PIM1 | |
| SCHEMBL16226676 | 0.84 | EPHX2 (0.86) | EPHX2EGFRCDK4CCND1PIM1 | |
| SCHEMBL28907722 | 0.82 | EPHX2 (0.78) | EPHX2PIM1BCL2MCL1ACLY | |
| SCHEMBL27927334 | 0.82 | EPHX2 (0.86) | EPHX2EGFRCDK4CCND1PIM1 | |
| SCHEMBL31746123 | 0.82 | EPHX2 (0.63) | EPHX2EGFRCDK4CCND1PIM1 | |
| SCHEMBL16226754 | 0.81 | EPHX2 (1.00) | EPHX2PIM1ACLYMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140335050-A1 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER | THE GENERAL HOSPITAL CORPORATION (US) | 2014-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140335050-A1 | METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER | IL2RA, CD74, IL2 | EPHX2 2549/4885EGFR 656/4885CDK4 1290/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.